COYA Coya Therapeutics Inc

Price (delayed)

$5.04

Market cap

$118.23M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.07

Enterprise value

$75.05M

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 47
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 28

Headquartered in Houston, TX, Coya Therapeutics, Inc. is a clinical-stage biotechnology company developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells ("Tregs") to target ...

Highlights
The EPS is up by 14% year-on-year and by 7% since the previous quarter
The company's quick ratio has surged by 86% YoY but it fell by 14% QoQ
The company's equity has surged by 53% YoY but it fell by 12% QoQ
COYA's net income is down by 7% YoY and by 2.6% QoQ

Key stats

What are the main financial stats of COYA

COYA stock price

How has the Coya Therapeutics stock price performed over time
Intraday
-4.91%
1 week
13%
1 month
3.49%
1 year
-4%
YTD
-13.1%
QTD
-13.85%

Financial performance

How have Coya Therapeutics's revenue and profit performed over time
Revenue
$8.02M
Gross profit
$8.02M
Operating income
-$23.15M
Net income
-$21.67M
Gross margin
100%
Net margin
-270.2%
Coya Therapeutics's operating margin has soared by 95% YoY
Coya Therapeutics's net margin has soared by 94% YoY
COYA's net income is down by 7% YoY and by 2.6% QoQ
Coya Therapeutics's operating income has decreased by 2.8% from the previous quarter and by 2.3% YoY

Price vs fundamentals

How does COYA's price correlate with its fundamentals

Growth

What is Coya Therapeutics's growth rate over time

Valuation

What is Coya Therapeutics stock price valuation
P/E
N/A
P/B
2.73
P/S
14.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.36
The EPS is up by 14% year-on-year and by 7% since the previous quarter
The company's equity has surged by 53% YoY but it fell by 12% QoQ
The P/B is 2.5% above the last 4 quarters average of 2.8
COYA's P/S is 3.7% below its last 4 quarters average of 16.1

Efficiency

How efficient is Coya Therapeutics business performance
The return on sales has surged by 95% year-on-year
Coya Therapeutics's return on equity has increased by 13% YoY and by 7% QoQ
The ROA has grown by 11% YoY and by 5% from the previous quarter

Dividends

What is COYA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for COYA.

Financial health

How did Coya Therapeutics financials performed over time
The company's quick ratio has surged by 86% YoY but it fell by 14% QoQ
COYA's current ratio has surged by 80% year-on-year but it is down by 11% since the previous quarter
Coya Therapeutics's debt is 100% less than its equity
The company's equity has surged by 53% YoY but it fell by 12% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.